These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 12042893

  • 21. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K, Müller-Berghaus J, Fuchshuber A, Michalk D, Querfeld U.
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [Abstract] [Full Text] [Related]

  • 22. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C, Melvin T, Kim Y.
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [Abstract] [Full Text] [Related]

  • 27. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J, Jankowski A, Szozda A.
    Pol Tyg Lek; 2017 Aug; 48(20-22):455-9. PubMed ID: 8170809
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T, Ksiazek J, Wieteska-Klimczak A, Gorzkowska-Paczwa M, Dorywalski T, Tysarowska A.
    Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
    [Abstract] [Full Text] [Related]

  • 33. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 34. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
    Elmas AT, Tabel Y, Elmas ON.
    Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.